Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

5.20USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$5.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,133
52-wk High
$8.14
52-wk Low
$2.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.53 December 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 1.13 1.58 0.70 0.70
Quarter Ending Mar-18 2 0.70 1.40 0.00 --
Year Ending Dec-17 4 4.84 5.30 4.40 5.95
Year Ending Dec-18 4 1.95 5.00 0.00 0.50
Earnings (per share)
Quarter Ending Dec-17 4 -0.53 -0.46 -0.60 -0.65
Quarter Ending Mar-18 2 -0.52 -0.44 -0.61 --
Year Ending Dec-17 4 -1.95 -1.89 -2.03 -2.45
Year Ending Dec-18 4 -2.13 -2.00 -2.33 -2.57

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.09 1.26 0.17 15.95
Quarter Ending Jun-17 1.29 1.48 0.19 14.87
Quarter Ending Mar-17 1.68 0.98 0.70 41.66
Quarter Ending Dec-16 3.36 1.25 2.11 62.88
Quarter Ending Sep-16 1.90 1.15 0.75 39.53

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.13 1.13 1.13 1.10 0.70
Quarter Ending Mar-18 0.70 0.70 0.70 0.70 --
Year Ending Dec-17 4.84 4.84 4.85 4.66 5.95
Year Ending Dec-18 1.95 1.95 1.95 1.95 0.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 0
Earnings